also reported a low risk of hypoglycemia, with events occurring in similar proportions of patients with obesity but without diabetes who were treated with liraglutide 3.0 mg (1.3%) compared with placebo (1.0%) [37]
The potential of semaglutide and similar medications to aid in reducing alcohol consumption opens new avenues for treating alcohol use disorder
Clinical trials have demonstrated that individuals taking Semaglutide GLP-1 experienced notably greater weight loss than those using other GLP-1 agonists or a placebo
Why Scale Watchers Rx Is Nashvilles Leader in Hormone-Guided Weight Loss When it comes to GLP-1 therapy, the provider matters just as much as the medication
O'Reilly MW, Taylor AE, Crabtree NJ, Hughes BA, Capper F, Crowley RK, Stewart PM, Tomlinson JW, Arlt W